LGALS3 and pulmonary fibrosis: The serum concentration of Gal-3 in patients hospitalized with AHF depends not only on cardiac involvement but also on many other conditions, such as renal dysfunction, hepatic cirrhosis, pulmonary fibrosis, cancer disease, and obesity.